Lupin hits seven-month high as US portfolio and margins drive gains (Soban News)

Lupin’s stock rose after a strong Q2FY26 led by the US business and a sharp jump in margins. Analysts see Tolvaptan exclusivity and complex generics supporting earnings momentum​Lupin’s stock rose after a strong Q2FY26 led by the US business and a sharp jump in margins. Analysts see Tolvaptan exclusivity and complex generics supporting earnings momentum ​Latest News [ SOBAN NEWS: International and National ]